Globeflex Capital L P Pacira Bio Sciences, Inc. Transaction History

Globeflex Capital L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$50.47 - $66.26 $622,850 - $817,714	-12,341 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $115,113 - $139,545	-2,215 Reduced 15.22%	12,341 $742,000
Q2 2020 Aug 12, 2020	BUY	$30.8 - $52.47 $24,732 - $42,133	803 Added 5.84%	14,556 $764,000
Q1 2020 May 13, 2020	BUY	$28.4 - $50.7 $390,585 - $697,277	13,753 New	13,753 $461,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $870M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.